Table 6.

Proportion of good adherence (≥80%) to 5-ASA oral treatments

Adherence: % (95% CI)		5-ASA oral formulations
		total	time-dependent	pH-dependent	MMX
At 180 days after the concomitant use of topical preparation	Cohort 1	72.6 (69.7–75.6)	64.7 (58.1–71.3)*	68.5 (62.1–74.9)*	77.1 (72.6–81.7)
At 180 days after the index date	Total (cohorts 1 + 2)	72.5 (70.8–74.2)	67.5 (64.1–71.0)*	68.7 (65.2–72.3)*	78.2 (75.6–80.9)
	Cohort 1	76.2 (73.4–79.0)	68.1 (61.7–74.5)*	72.4 (66.3–78.6)*	80.2 (75.9–84.5)
	Cohort 2	70.7 (68.6–72.8)	67.3 (63.3–71.4)*	67.1 (62.8–71.4)*	77.2 (73.8–80.5)

Data: % (95% CI).

*p < 0.05 versus MMX, χ² test.